相关实验视频
Updated: Jul 2, 2025

13:28
Methodology for Sputum Induction and Laboratory Processing
Published on: December 17, 2017
27.6K
血清IgA水平与低百分比的强迫呼气体积在喘的第一秒之间的关系
Sahoko Imoto1,2, Maho Suzukawa1, Kazufumi Takada1,3
1National Hospital Organization, Tokyo National Hospital, Tokyo, Japan.
概括
在喘患者中,较高的免疫球蛋白A (IgA) 水平与肺功能恶化和炎症增加相关,以较低的FEV1%和较高的MIP-1β. 这表明IgA可能会恶化喘的结果.
科学领域:
- 免疫学 免疫学 免疫学
- 呼吸系统医学 呼吸系统医学
- 生物标志物研究 生物标志物研究
背景情况:
- 免疫球蛋白A (IgA) 涉及呼吸道炎症疾病,如喘.
- 了解血清IgA在喘发病过程中的作用对于开发向疗法至关重要.
研究的目的:
- 为了研究血清IgA水平和喘患者的临床指标之间的关联.
- 为了确定与喘中血清IgA水平较高相关的特定生物标志物.
主要方法:
- 针对572名喘患者进行的NHOM喘研究的后期分析.
- 测量了血清IgA水平,并使用多变量线性回归分析了与临床变量和生物标志物的关联.
- 高IgA和低IgA喘组之间的临床指数的比较.
主要成果:
- 在第一秒内强制呼气量比例较低 (%FEV1),较高的血清eotaxin,较低的血清ST2和较高的血清MIP-1β与血清IgA增加显著相关.
- 与低IgA患者相比,高血清IgA (≥238 mg/dL) 的喘患者表现出明显较低的FEV1%,更高的瘤率和高血清MIP-1β水平.
结论:
- 血清IgA水平升高与喘结果较差有关,包括肺功能降低 (%FEV1).
- 在高IgA喘患者的血清MIP-1β水平增加表明IgA在增强气道炎症中的作用.
相关概念视频
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma: Pathogenesis and Management
398
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
398
Drugs Used in Lower Respiratory Disorders: Overview
442
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
442

